Cargando…
P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430900/ http://dx.doi.org/10.1097/01.HS9.0000970596.51835.28 |
| _version_ | 1785091070211653632 |
|---|---|
| author | Einsele, Hermann Moreau, Philippe Bahlis, Nizar J Bhutani, Manisha Vincent, Laure Karlin, Lionel Perrot, Aurore Goldschmidt, Hartmut van de Donk, Niels W.C.J. Ocio, Enrique Martinez-Lopez, Joaquín Rodríguez-Otero, Paula Dytfeld, Dominik Diels, Joris Strulev, Vadim Haddad, Imene Renaud, Thomas Ammann, Eric Cabrieto, Jedelyn Perualila, Nolen Gan, Ryan Zhang, Youyi Parekh, Trilok Albrecht, Claire Weisel, Katja Mateos, Maria-Victoria |
| author_facet | Einsele, Hermann Moreau, Philippe Bahlis, Nizar J Bhutani, Manisha Vincent, Laure Karlin, Lionel Perrot, Aurore Goldschmidt, Hartmut van de Donk, Niels W.C.J. Ocio, Enrique Martinez-Lopez, Joaquín Rodríguez-Otero, Paula Dytfeld, Dominik Diels, Joris Strulev, Vadim Haddad, Imene Renaud, Thomas Ammann, Eric Cabrieto, Jedelyn Perualila, Nolen Gan, Ryan Zhang, Youyi Parekh, Trilok Albrecht, Claire Weisel, Katja Mateos, Maria-Victoria |
| author_sort | Einsele, Hermann |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430900 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309002023-08-17 P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA Einsele, Hermann Moreau, Philippe Bahlis, Nizar J Bhutani, Manisha Vincent, Laure Karlin, Lionel Perrot, Aurore Goldschmidt, Hartmut van de Donk, Niels W.C.J. Ocio, Enrique Martinez-Lopez, Joaquín Rodríguez-Otero, Paula Dytfeld, Dominik Diels, Joris Strulev, Vadim Haddad, Imene Renaud, Thomas Ammann, Eric Cabrieto, Jedelyn Perualila, Nolen Gan, Ryan Zhang, Youyi Parekh, Trilok Albrecht, Claire Weisel, Katja Mateos, Maria-Victoria Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430900/ http://dx.doi.org/10.1097/01.HS9.0000970596.51835.28 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Einsele, Hermann Moreau, Philippe Bahlis, Nizar J Bhutani, Manisha Vincent, Laure Karlin, Lionel Perrot, Aurore Goldschmidt, Hartmut van de Donk, Niels W.C.J. Ocio, Enrique Martinez-Lopez, Joaquín Rodríguez-Otero, Paula Dytfeld, Dominik Diels, Joris Strulev, Vadim Haddad, Imene Renaud, Thomas Ammann, Eric Cabrieto, Jedelyn Perualila, Nolen Gan, Ryan Zhang, Youyi Parekh, Trilok Albrecht, Claire Weisel, Katja Mateos, Maria-Victoria P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title | P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full | P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_fullStr | P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full_unstemmed | P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_short | P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_sort | p923: comparative effectiveness of talquetamab vs real-world physician’s choice of treatment in locommotion and momment for patients with triple-class exposed relapsed/refractory multiple myeloma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430900/ http://dx.doi.org/10.1097/01.HS9.0000970596.51835.28 |
| work_keys_str_mv | AT einselehermann p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT moreauphilippe p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT bahlisnizarj p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT bhutanimanisha p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT vincentlaure p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT karlinlionel p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT perrotaurore p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT goldschmidthartmut p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT vandedonknielswcj p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT ocioenrique p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT martinezlopezjoaquin p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT rodriguezoteropaula p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT dytfelddominik p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT dielsjoris p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT strulevvadim p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT haddadimene p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT renaudthomas p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT ammanneric p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT cabrietojedelyn p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT perualilanolen p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT ganryan p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT zhangyouyi p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT parekhtrilok p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT albrechtclaire p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT weiselkatja p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma AT mateosmariavictoria p923comparativeeffectivenessoftalquetamabvsrealworldphysicianschoiceoftreatmentinlocommotionandmommentforpatientswithtripleclassexposedrelapsedrefractorymultiplemyeloma |